Laboratory diagnosis of Talaromyces marneffei associated bloodstream infections

TANG Sishi; LI Yan; CHEN Zhixing; DAI Zhongqiu; AO Keping; HE Chao

PDF(197 KB)

Medical Journal of the Chinese People Armed Police Forces ›› 2020, Vol. 31 ›› Issue (12) : 1033-1037.

ORIGINAL ARTICLES

Laboratory diagnosis of Talaromyces marneffei associated bloodstream infections

TANG Sishi¹, LI Yan², CHEN Zhixing¹, DAI Zhongqiu¹, AO Keping¹, HE Chao¹

Author information +

History +

Abstract

Objective To establish a laboratory diagnostic pathway of talaromyces marneffei associated bloodstream infection so as to provide reference for the diagnosis and treatment of relateddiseases.Methods Peripheral blood samples were collected from the patients suspected with fungal bloodstream infection before whole blood cell count, smearing and microscopy were performed for these specimens. Blood specimens were cultured and detected with biphasic temperature culture when filamentous fungi were found in the smear of instrument alarmed-positive specimens. The suspected colonies were identified by morphology and Matrix-Assisted Laser Desorption/ Ionization Time of Flight (MALDI-TOF MS). Plasma (1,3)-β-D-glucan was determined by colorimetry. The clinical data of the patients was collected for statistical analysis.Results Twenty-four cases were included in this study, and the average age was 42.2 years old.The ratio of males to females was 7:1, and their underlying diseases were acquired immune deficiency syndrome. Among these patients, 8 (34.8%) had low white blood count and 20(87.0%) had decreased hemoglobin. All the 24 strains were identified as T. marneffei by morphology and MALDI-TOF MS. In one case (4.2%), specific morphology of T. marneffei was observed in the peripheral blood smear. Five(62.5%) of the eight patients were positive for plasma (1,3)-β-D-glucan. Among the 16 hospitalized patients, 10(62.5%)had respiratory symptoms, and 12 (75.0%) suffered secondary infections, whose median length of hospital stay was 12.0 days, and hospital mortality was 52.3%.Conclusions The laboratory diagnosis of T. marneffei associated bloodstream infections should be combined with peripheral blood cell count, blood culture, (1,3)-β-D-glucan test and clinical data.Patients who have poor immunityare more vulnerable to secondary infection and poor prognosis.

Key words

talaromyces marneffei / bloodstream infection / laboratory diagnosis

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

TANG Sishi, LI Yan, CHEN Zhixing, DAI Zhongqiu, AO Keping, HE Chao. Laboratory diagnosis of Talaromyces marneffei associated bloodstream infections[J]. Medical Journal of the Chinese People Armed Police Forces. 2020, 31(12): 1033-1037

References

[1] Huang X, He G, Lu S, et al. Role of rhizomys pruinosus as a natural animal host of penicillium marneffei in guangdong, China[J]. Microb Biotechnol, 2015, 8(4): 659-664.
[2] Chen R, Ye F, Luo Q, et al. Disseminated penicilliosis marneffei in immunocompetent patients: a report of two cases[J]. Indian J Med Microbi, 2015, 33(1):161-165.
[3] Chitasombat M, Supparatpinyo K. Penicillium marneffeiInfection in immunocompromised host[J]. Curr Infect Dis Rep, 2013, 7(1): 44-50.
[4] 曹静,袁雅璐,成卫英,等. HIV阴性的马尔尼菲蓝状菌病研究进展[J]. 中国皮肤性病学杂志, 2018, 32(4): 462-465.
[5] Le T, Wolbers M, Chi N H, et al. Epidemiology, seasonality, and predictors of outcome of AIDS-associated penicillium marneffei infection in ho chi minh city, viet nam[J]. Clin Infect Dis, 2011, 52(7): 945-952.
[6] 彭帆,钟正,孔祥龙,等. 22例艾滋病合并马尔尼菲篮状菌感染患者的临床特征[J]. 中国感染控制杂志, 2018, 17(7): 610-614.
[7] 李莉,章强强. 播散性马尔尼菲蓝状菌病1例及文献复习[J]. 中国皮肤性病学杂志,2018,32(2):187-191.
[8] Chan J F, Lau S K, Yuen K Y, et al. Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients[J]. Emerg Microbes Infec, 2016, 5(3): e19.
[9] Le T, Kinh N V, Cuc N T, et al. A Trial of Itraconazole or Amphotericin B for HIV-Associated Talaromycosis[J]. N Engl J Med, 2017, 376(24): 2329-2340.
[10] 李仕雄,许超宇,吕日英,等. 马尔尼菲蓝状菌病预后模型的构建[J]. 实用医学杂志, 2019, 35(16): 2603-2606.
[11] 叶萍,孔晋亮,吴聪,等. 不同方案治疗马尔尼菲青霉病的疗效分析[J]. 中华医院感染学杂志, 2016, 26(18): 4128-4131.
[12] 尹秀云,梁钰英,于农,等. 临床少见丝状真菌的实验室诊断[J]. 军事医学, 2015, 39(11): 855-858.
[13] 李营,屈平华,陈东科,等. ITS基因测序分析对89株病原真菌鉴定的应用评价[J]. 临床检验杂志, 2015, 33(11): 860-863.
[14] 税国顺,何代莉,毛翠. 马尔尼菲青霉菌、荚膜组织胞浆菌和黑热病杜利小体的实验诊断与鉴别[J]. 中国基层医药, 2005, 12(4):499-500.
[15] 杨凌婧,范红. 艾滋病马尔尼菲青霉菌感染研究进展[J]. 实用医院临床杂志, 2015, 12(5): 245-247.
[16] 中华人民共和国卫生部. 人间传染的病原微生物名录[EB/OL].(2013-01-13). http://www.icdc.cn/html/shengwuanquan/guanlizhidu/2013/0117/1733.html
[17] Dixon P, Davies P, Hollingworth W, et al. A systematic review of matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry compared to routine microbiological methods for the time taken to identify microbial organisms from positive blood cultures[J]. Eur J Clin Microbiol Infect Dis, 2015, 34(5): 863-876.
[18] Werno A M, Christner M, Anderson T P, et al. Differentiation of streptococcus pneumoniae from nonpneumococcal streptococci of the Streptococcus mitis group by matrix-assisted laser desorption ionization-time of flight mass spectrometry[J]. J Clin Microbiol, 2012, 50(9): 2863.
[19] 胡家光,蒋忠胜,温小凤,等. 血浆(1-3)-β-D葡聚糖检测诊断艾滋病患者合并播散性马尔尼菲青霉菌病的临床价值[J]. 中华医院感染学杂志, 2015, 22: 5128-5130.
[20] 金颖康,吴上志,辜淑君,等. 儿童非人类免疫缺陷病毒感染相关播散性马尔尼菲青霉菌病15例临床回顾分析[J]. 中国实用儿科杂志, 2018, 33(9): 707-711.
[21] 何小庆, 鲁雁秋,周怡宏,等. 重庆地区56例AIDS合并播散性马尔尼菲篮状菌病患者临床特征及死亡危险因素分析[J]. 传染病信息, 2018, 31(6):521-524.